Anaesthesia

Johan Ræder, Chief consultant and Professor, Dept of Anaesthesiology, Oslo University Hospital.
Statement on the PainMonitor© and professor Hanne Storm MD.PhD the CEO and founder of Med-Storm Innovation AS:

“I have known and collaborated with Hanne Storm for the last 17-18 years. We have mutual responsibility of five Medline registered original research papers and one PhD student.
Hanne Storm is an exceptionally innovative, efficient and hard working researcher; she has done her research in parallel with tutor work for medical students and successful development of business and certification work on her own patency on the stress measure device, Pain Monitor.

She has been the main supervisor for one PhD candidate and has numerous collaboration projects with leading scientists in Norway and internationally.

She has exceptional qualities in hypotheses generation, in getting collaboration from other research groups, and in making complex and tough projects into realities.

She is also a very pleasant person to collaborate with; always friendly, open-minded and listening but still consistent in getting results and conclusions from whatever she is into.

The PainMonitor is a unique and very promising tool for evaluation and objective (quantitative) measurement of nociceptive stimulation, which is reported as pain in the awake patient. As pain is a subjective experience based on nociceptive input in combination with psychological mechanisms, it is very hard to measure directly, but a lot of surrogate tools have been developed, such as EEG devices, pupillometry, pletysmograhy, etc.

The unique feature of the PainMonitor is the sophisticated calculation of sweat bursts, which correlates very well with nociception and pain in many patient models tested: general anaesthesia, pediatric/neonatal care, post-operative pain, intensive care, pain during sedation, etc.

Compared to other devices the response is very rapid, non-influenced by use of most drugs, cheap, non-invasive and now commercially available.

Still, there is a huge potential in developing this simple and objective tool into something that could be a routine part of monitoring all patients during surgery or intensive care.

As more than 1 out of 7-8 persons in the Western world is subjected to this kind of care during an average year, there is a great commercial potential for the PainMonitor in such a context.”

e-mail: johan.rader@medisin.uio.no
Ph: +47 922 49 669